Last reviewed · How we verify
NCT03181568
Evaluating Surface Area Reduction Using MolecuLight Imaging Device
NA trial testing MolecuLight i:X™ Imaging Device in Wound in 80 participants. Status unknown.
29 September 2017
Quick facts
| Lead sponsor | Calver Pang |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | supportive care |
| Enrollment | 80 |
| Start date | 10 July 2017 |
| Primary completion | 29 September 2017 |
| Estimated completion | 29 September 2017 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- MolecuLight i:X™ Imaging Device
- Wound care
Conditions studied
- Wound — all drugs for Wound →
- Wound Infection — all drugs for Wound Infection →
Sponsor
Calver Pang
Who can join
18 and older, any sex, with Wound or Wound Infection. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
12-week single-blind, prospective, randomized, controlled, pilot clinical trial assessing The MolecuLight i:X Imaging Device in chronic wounds. This device guides clinicians to inspect, sample, debride or further evaluate areas within or around a wound where potentially harmful bacteria appear under violet light illumination resulting in better overall care and accelerated surface area reduction compared to current standard care. The study aims to determine if this device aids in the healing of chronic wounds by reduction in size of wound compared to current standard of care.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03181568
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Wound
Currently open trials in the same condition.
- NCT07398534 — PICO Negative Pressure for Uninfected Foot Ulcers and Wound Dehiscence (BALPIC) · NA · active not recruiting
- NCT06957964 — Prophylactic Negative Pressure Wound Therapy in Laparotomy Wounds: A Randomized Clinical Trial · NA · recruiting
- NCT06801626 — Novel Strategies for Reducing Burn Scar Itch · Phase 3 · recruiting
- NCT06321978 — Mepilex Border Flex Utilization Pilot Spain · recruiting
- NCT06138964 — Comparing the Effect of siSPARC Microneedle Patch Versus siSPARC+siLR4A Microneedle Patch on Post-surgical Scars · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03181568 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Calver Pang
- Last refreshed: 9 June 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03181568.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing